Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Behind the scenes, participating manufacturers provide the drugs at a net price of $245 per month
Heres a simple breakdown based on studies: Retatrutide: Side effects and safety considerations Retatrutide is still being studied, but clinical trials already give a helpful picture of what side effects people might experience
Mounjaro (tirzepatide) was FDA-approved in spring 2022 for managing type 2 diabetes and greenlighted for chronic weight management in November 2023 as Zepbound (tirzepatide)
Um where does that development stand and it sounds like uh, you know, maybe I'm wrong, it sounds like Pfizer is going to probably just try to jump directly to the oral route with this uh acquisition or or where where are we at there
US$ 25.47
US$ 22.84
US$ 22.17
US$ 24.64
US$ 23.00
US$ 22.03
US$ 29.56
